Transketolase-like protein 1 expression predicts poor prognosis in colorectal cancer

Cancer Biology and Therapy

Volumn 17, Issue 2, 2016, Pages 163-168

  Ahopelto, Kaisa ^a,b   Böckelman, Camilla ^b,c   Hagström, Jaana ^a,b   Koskensalo, Selja ^a,b   Haglund, Caj ^a,b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c VAASA CENTRAL HOSPITAL   (Finland)

Author keywords

Colon cancer; colorectal cancer; immunohistochemistry; prognosis; rectal cancer; TKTL1; tumor marker

Indexed keywords

TRANSKETOLASE; TRANSKETOLASE LIKE PROTEIN 1; UNCLASSIFIED DRUG; TKTL1 PROTEIN, HUMAN; TUMOR MARKER;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; DISEASE SPECIFIC SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; TISSUE MICROARRAY; BIOSYNTHESIS; COLORECTAL TUMOR; DISEASE FREE SURVIVAL; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; PATHOLOGY; PENTOSE PHOSPHATE CYCLE; PROGNOSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; PENTOSE PHOSPHATE PATHWAY; PROGNOSIS; TISSUE ARRAY ANALYSIS; TRANSKETOLASE;

EID: 84961206495     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.1080/15384047.2015.1121347     Document Type: Article

References (26)

1. O.Warburg, K.Posener, E.Negelein. Über den Stoffwechsel der Carcinomzelle. Biochem Z 1924; 152:309-44; http://dx.doi.org/10.1007/BF01504608
2. R.Wittig, J.F.Coy. The role of glucose metabolism and glucose-associated signalling in cancer. Perspect Medicin Chem 2008; 1:64-82; PMID:19812737
3. X.Xu, A.Hausen Zur, J.F.Coy, M.Löchelt. Transketolase-like protein 1 (TKTL1) is required for rapid cell growth and full viability of human tumor cells. Int J Cancer 2009; 124:1330-7; PMID:19065656; http://dx.doi.org/10.1002/ijc.24078
4. S.Langbein, M.Zerilli, A.Hausen Zur, W.Staiger, K.Rensch-Boschert, N.Lukan, J.Popa, M.P.Ternullo, A.Steidler, C.Weiss, Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted. Br J Cancer 2006; 94:578-85; PMID:16465194; http://dx.doi.org/10.1038/sj.bjc.6602962
5. H.Schultz, D.Kähler, D.Branscheid, E.Vollmer, P.Zabel, T.Goldmann. TKTL1 is overexpressed in a large portion of non-small cell lung cancer specimens. Diagn Pathol 2008; 3:35; PMID:18700018; http://dx.doi.org/10.1186/1746-1596-3-35
6. W.Sun, Y.Liu, C.A.Glazer, C.Shao, S.Bhan, S.Demokan, M.Zhao, M.A.Rudek, P.K.Ha, J.A.Califano. TKTL1 is activated by promoter hypomethylation and contributes to head and neck squamous cell carcinoma carcinogenesis through increased aerobic glycolysis and HIF1alpha stabilization. Clin Cancer Res 2010; 16:857-66; PMID:20103683; http://dx.doi.org/10.1158/1078-0432.CCR-09-2604
7. G.Kayser, W.Sienel, B.Kubitz, D.Mattern, E.Stickeler, B.Passlick, M.Werner, A.Hausen Zur. Poor outcome in primary non-small cell lung cancers is predicted by transketolase TKTL1 expression. Pathology 2011; 43:719-24; PMID:22027741; http://dx.doi.org/10.1097/PAT.0b013e32834c352b
8. M.Krockenberger, J.B.Engel, M.Schmidt, N.Kohrenhagen, S.F.M.Häusler, Y.Dombrowski, M.Kapp, J.Dietl, A.Honig. Expression of transketolase-like 1 protein (TKTL1) in human endometrial cancer. Anticancer Res 2010; 30:1653-9; PMID:20592357
9. M.Schmidt, H.-U.Voelker, M.Kapp, M.Krockenberger, J.Dietl, U.Kammerer. Glycolytic phenotype in breast cancer: activation of Akt, up-regulation of GLUT1, TKTL1 and down-regulation of M2PK. J Cancer Res Clin Oncol 2010; 136:219-25; PMID:19655166; http://dx.doi.org/10.1007/s00432-009-0652-y
10. H.Chen, J.-X.Yue, S.-H.Yang, H.Ding, R.-W.Zhao, S.Zhang. Overexpression of transketolase-like gene 1 is associated with cell proliferation in uterine cervix cancer. J Exp Clin Cancer Res 2009; 28:43; PMID:19331662; http://dx.doi.org/10.1186/1756-9966-28-43
11. J.Schwaab, K.Horisberger, P.Ströbel, B.Bohn, D.Gencer, G.Kähler, P.Kienle, S.Post, F.Wenz, W.-K.Hofmann, Expression of Transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy. BMC Cancer 2011; 11:363; PMID:21854597; http://dx.doi.org/10.1186/1471-2407-11-363
12. C.A.Lange, J.Tisch-Rottensteiner, D.Böhringer, G.Martin, J.Schwartzkopff, C.Auw-Haedrich. Enhanced TKTL1 expression in malignant tumors of the ocular adnexa predicts clinical outcome. Ophthalmology 2012; 119:1924-9; PMID:22658715; http://dx.doi.org/10.1016/j.ophtha.2012.03.037
13. M.Grimm, S.Hoefert, O.Luz, S.Reinert, J.Polligkeit. Transketolase-like protein 1 expression in recurrent oral squamous cell carcinoma after curative resection: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol 2013; 116:e173-8; PMID:22819458; http://dx.doi.org/10.1016/j.oooo.2011.12.022
14. M.Grimm, A.Munz, P.Teriete, T.Nadtotschi, S.Reinert. GLUT-1(+)/TKTL1(+) coexpression predicts poor outcome in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol 2014; 117:743-53; PMID:24703406; http://dx.doi.org/10.1016/j.oooo.2014.02.007
15. J.Ferlay, I.Soerjomataram, R.Dikshit, S.Eser, C.Mathers, M.Rebelo, D.M.Parkin, D.Forman, F.Bray. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2014; 136:359–386; PMID:25220842
16. C.Böckelman, B.E.Engelmann, T.Kaprio, T.F.Hansen, B.Glimelius. Risk of recurrence in patients with colon cancer stage II and III: A systematic review and meta-analysis of recent literature. Acta Oncol 2015; 54:5-16; PMID:25430983; http://dx.doi.org/10.3109/0284186X.2014.975839
17. L.-H.Hu, J.-H.Yang, D.-T.Zhang, S.Zhang, L.Wang, P.-C.Cai, J.-F.Zheng, J.-S.Huang. The TKTL1 gene influences total transketolase activity and cell proliferation in human colon cancer LoVo cells. Anticancer Drugs 2007; 18:427-33; PMID:17351395; http://dx.doi.org/10.1097/CAD.0b013e328013d99e
18. S.Bentz, A.Cee, E.Endlicher, K.A.Wojtal, A.Naami, T.Pesch, S.Lang, P.Schubert, M.Fried, A.Weber, Hypoxia induces the expression of transketolase-like 1 in human colorectal cancer. Digestion 2013; 88:182-92; PMID:24193262; http://dx.doi.org/10.1159/000355015
19. J.F.Coy, D.Dressler, J.Wilde, P.Schubert. Mutations in the transketolase-like gene TKTL1: clinical implications for neurodegenerative diseases, diabetes and cancer. Clin Lab 2005; 51:257-73; PMID:15991799
20. S.Diaz-Moralli, M.Tarrado-Castellarnau, C.Alenda, A.Castells, M.Cascante. Transketolase-like 1 expression is modulated during colorectal cancer progression and metastasis formation. PLoS ONE 2011; 6:e25323; PMID:21980427; http://dx.doi.org/10.1371/journal.pone.0025323
21. J.Rieger, O.Bähr, G.D.Maurer, E.Hattingen, K.Franz, D.Brucker, S.Walenta, U.Kammerer, J.F.Coy, M.Weller, ERGO: a pilot study of ketogenic diet in recurrent glioblastoma. Int J Oncol 2014; 44:1843-52; PMID:24728273; http://dx.doi.org/10.3892/ijo.2014.2382
22. J.Kononen, L.Bubendorf, A.Kallioniemi, M.Bärlund, P.Schraml, S.Leighton, J.Torhorst, M.J.Mihatsch, G.Sauter, O.P.Kallioniemi. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998; 4:844-7; PMID:9662379; http://dx.doi.org/10.1038/nm0798-844
23. A.Nocito, J.Kononen, O.P.Kallioniemi, G.Sauter. Tissue microarrays (TMAs) for high-throughput molecular pathology research. Int J Cancer 2001; 94:1-5; PMID:11668471; http://dx.doi.org/10.1002/ijc.1385
24. O.P.Kallioniemi, U.Wagner, J.Kononen, G.Sauter. Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genet 2001; 10:657-62; PMID:11257096; http://dx.doi.org/10.1093/hmg/10.7.657
25. J.Torhorst, C.Bucher, J.Kononen, P.Haas, M.Zuber, O.R.Köchli, F.Mross, H.Dieterich, H.Moch, M.Mihatsch, Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol 2001; 159:2249-56; PMID:11733374; http://dx.doi.org/10.1016/S0002-9440(10)63075-1
26. C.Böckelman, S.Koskensalo, J.Hagström, M.Lundin, A.Ristimäki, C.Haglund. CIP2A overexpression is associated with c-Myc expression in colorectal cancer. Cancer Biol Ther 2012; 13:289-95; PMID:22310977; http://dx.doi.org/10.4161/cbt.18922